Vir Biotechnology, Inc. (VIR)
NASDAQ: VIR · Real-Time Price · USD
9.00
+0.04 (0.45%)
Aug 13, 2026, 4:00 PM EDT - Market closed
Vir Biotechnology Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 303.23 | 68.56 | 74.21 | 86.18 | 1,616 | 1,095 | |
Revenue Growth | 1495.93% | -7.61% | -13.89% | -94.67% | 47.50% | 1334.39% |
Cost of Revenue | 0.02 | 0.03 | 0.85 | 2.77 | 146.32 | 65.87 |
Gross Profit | - | 68.53 | 73.36 | 83.42 | 1,469 | 1,030 |
Selling, General & Admin | 99.38 | 92.07 | 119.03 | 174.44 | 161.76 | 160.79 |
Research & Development | 484.02 | 455.97 | 506.5 | 579.72 | 474.65 | 448.01 |
Other Operating Expenses | - | -0.18 | 35 | 13.56 | - | - |
Total Operating Expenses | 583.4 | 547.86 | 660.53 | 767.72 | 636.41 | 608.8 |
Operating Income | -280.19 | -479.33 | -587.17 | -684.31 | 833.07 | 420.75 |
Interest Income | 33.32 | 40.24 | 71.81 | 86.99 | 28.09 | 0.44 |
Other Non-Operating Income (Expense) | -4.43 | 1.32 | -7.75 | -30.88 | -106.88 | 128.61 |
Total Non-Operating Income (Expense) | 28.89 | 41.56 | 64.06 | 56.11 | -78.79 | 129.05 |
Pretax Income | -251.3 | -437.77 | -523.11 | -628.19 | 754.28 | 549.8 |
Provision for Income Taxes | 0.38 | 0.22 | -1.15 | -13.08 | 238.44 | 21.22 |
Net Income | -251.68 | -437.99 | -521.96 | -615.12 | 515.84 | 528.58 |
Minority Interest in Earnings | - | - | - | 0.06 | - | - |
Net Income to Common | -251.68 | -437.99 | -521.96 | -615.06 | 515.84 | 528.58 |
Net Income Growth | - | - | - | - | -2.41% | - |
Shares Outstanding (Basic) | 148 | 139 | 136 | 134 | 133 | 130 |
Shares Outstanding (Diluted) | 149 | 139 | 136 | 134 | 135 | 133 |
Shares Change | 8.20% | 1.67% | 1.58% | -0.50% | 1.03% | 11.98% |
EPS (Basic) | -1.85 | -3.16 | -3.83 | -4.59 | 3.89 | 4.07 |
EPS (Diluted) | -1.86 | -3.16 | -3.83 | -4.59 | 3.83 | 3.96 |
EPS Growth | - | - | - | - | -3.28% | - |
Free Cash Flow | -202.93 | -396.61 | -453.65 | -800.36 | 1,595 | -69.41 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -1.37 | -2.86 | -3.33 | -5.97 | 11.83 | -0.52 |
Gross Margin | 100.00% | 99.96% | 98.86% | 96.79% | 90.94% | 93.99% |
Operating Margin | -92.40% | -699.18% | -791.27% | -794.04% | 51.56% | 38.41% |
Profit Margin | -83.00% | -638.88% | -703.40% | -713.76% | 31.92% | 48.25% |
FCF Margin | -66.92% | -578.52% | -611.35% | -928.71% | 98.73% | -6.34% |
EBITDA | -268.68 | -467.65 | -572.61 | -664.85 | 839.85 | 426.56 |
EBITDA Margin | -88.61% | -682.14% | -771.65% | -771.47% | 51.98% | 38.94% |
EBIT | -280.19 | -479.33 | -587.17 | -684.31 | 833.07 | 420.75 |
EBIT Margin | -92.40% | -699.18% | -791.27% | -794.04% | 51.56% | 38.41% |
Effective Tax Rate | -0.15% | -0.05% | 0.22% | 2.08% | 31.61% | 3.86% |